FR3021844: Proteasomal inhibitors useful for osteogenic activity and pharmaceutical composition thereof [osteo-heal]

Acces sibility Controls

A method for prevention and/or treatment of diminution of bone tissue using a composition comprising a compound selected from Withaferin A (WFA), Withanolide A, and Withanone. The composition showed enhanced WFA bioavailability in rodents against plain WFA, promotes bone marrow cell differentiation, and increases the percent of bone volume to tissue volume (BV/TV%) by 3 folds as compared to free Withaferin A (WFA).

Patent No:: FR3021844
Application No:: 14759348
Filing Date:: 20-01-2016
Issue Date:: 13-11-2019
Applicant:: CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
Inventor(s):: Prabhat Ranjan Mishra; Ritu Trivedi; Divya Singh; Priyanka Kushwaha; Vikram Khedgikar; Sulekha Adhikari; Dharmendra Choudhary; Jyoti Swarup; Avinash Kumar; Anirudha Karvande; Ashwni Verma; Shweta Sharma; Prabodh Trivedi; Neelam S Sangwan; Rajendra S Sangwan
Country:: France

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Acces sibility Controls

Patents